Business & Economy · 21 views
Cheap GLP - 1 copy grabs attention as Hims stock falters
NEW YORK CITY, New York: Hims & Hers sent ripples through the pharmaceutical world by unveiling a weight-loss pill priced at just US$49 a month, but the headline-grabbing move failed to lift its battered stock.
Summary
NEW YORK CITY, New York: Hims & Hers sent ripples through the pharmaceutical world by unveiling a weight-loss pill priced at just US$49 a month, but the headline-grabbing move failed to lift its battered stock. Shares of the telehealth and compounding company jumped sharply at the open before reversing course to end the day down four percent, extending a slump that has erased about 60 percent of its market value since mid-October.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Business & Economy
Continue reading recent Business & Economy coverage
- ‘Poverty doesn’t have to be my reality’: I thought I’d have to rely on Social Security. Then I taught myself how to invest.Continue reading
- S&P 500 futures fall to start shortened week as oil prices climb: Live updatesContinue reading
- The Economic Fallout From a Potential Return to $100 OilContinue reading
- Brent crude nears $100 after strikes on Saudi energy sites amid renewed Mideast hostilitiesContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow